Alladapt is a series c plus startup based in United States. 1 investor tracked.
Alladapt is a company founded in 2019 headquartered in the United States. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
A clinical-stage biopharmaceutical company developing prescription therapeutics to address the unmet needs of patients with food allergies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.